Recent studies into retatrutide, a dual activator for GLP-1 and GIP receptors, are showing significant outcomes in treating weight gain and related second-type diabetes. Initial evidence suggest a unique mechanism https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/